insights_auto
Prečo akcie 0QF stúpli 8,22%?
Preskúmať podrobnejšiechevron_right
0QF:ETR
Moderna Inc
203,20 €
arrow_upward
+8,22%(+15,44) 1 d.
12. 10., 9:12:28 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 0QF…
Otvoriť
202,65 €
Vysoká
203,20 €
Nízka
202,45 €
Trh. kap.
89,83 mld.
Priem. obj.
28,88 tis.
Objem
5,67 tis.
Max. za 52 týž.
203,20 €
Min. za 52 týž.
19,37 €
Počet zamestnancov
5 tis.
Otvoriť
202,65 €
Vysoká
203,20 €
Nízka
202,45 €
Trh. kap.
89,83 mld.
Priem. obj.
28,88 tis.
Objem
5,67 tis.
Max. za 52 týž.
203,20 €
Min. za 52 týž.
19,37 €
Počet zamestnancov
5 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
ad-hoc-news.de
·
pred 1 hodinou
Moderna stock pre-market at EUR 202.00
Simply Wall Street
·
pred 1 dňom
Moderna Cancer Vaccine Buzz Has Retail Investors Searching Oncology Stocks
The Motley Fool
·
pred 1 dňom
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
Yahoo Finance
·
pred 1 dňom
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Informácie o subjekte Moderna Inc
Generálny riaditeľStéphane Bancel
Zamestnanci4,7 tis.
Dátum založeniasep 2010
Hlavné sídlo-
Odvetvie-